Abstract Cushing's disease (CD), or pituitary-dependent Cushing's syndrome, is a severe
endocrine disease caused by a corticotroph pituitary tumor and associated with increased …

Context: The metabolic syndrome (MetS) is a cluster of metabolic abnormalities that
increase the risk for type 2 diabetes mellitus and vascular disease. The common …

Cushing's syndrome (CS) patients have increased mortality primarily due to cardiovascular
events induced by glucocorticoid (GC) excess-related severe metabolic changes. Glucose …

Cushing's syndrome (CS) is a severe condition that results from chronic exposure to
elevated circulating cortisol levels; it is a rare but potentially life-threating condition …

Abstract Background Subclinical Cushing's syndrome (SCS) is defined as alterations in
hypothalamic–pituitary–adrenal axis without classic signs/symptoms of glucocorticoid …

Background: Whether glucocorticoid use contributes to a hypercoagulable state, and
thereby enhances the thrombotic risk, is controversial. Objective: We aimed to examine the …

Cushing's syndrome is associated with increased mortality, mainly due to cardiovascular
complications, which are sustained by the common development of systemic arterial …

Hypercortisolism is associated with various systemic manifestations, including central
obesity, arterial hypertension, glucose intolerance/diabetes mellitus, dyslipidemia …

Cushing's syndrome (CS) is associated with increased mortality that is driven by
cardiovascular, thromboembolic, and infection complications. Although these events are …

Background and objectives: Cushing's syndrome (CS) is associated with an increased
cardiovascular mortality and morbidity. Chronic endogenous and exogenous …